| Dr Stephanie Chung, MD | |
|
330 Western Blvd Ste 102, Glastonbury, CT 06033-4383 | |
| (860) 547-0306 | |
| Not Available |
| Full Name | Dr Stephanie Chung |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 7 Years |
| Location | 330 Western Blvd Ste 102, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932630449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 68977 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
Sophiris Bio Inc. today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection.
Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.
A new resource that identifies regions of the human genome that regulate gene expression may help scientists learn about and develop treatments for a number of human diseases, according to researchers at Duke's Institute for Genome Sciences & Policy (IGSP).
BioTek will present two opportunities for researchers to learn about new instruments and approaches to simplify their workflow at analytica 2016, the 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference.
› Verified 3 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
Sophiris Bio Inc. today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection.
Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.
A new resource that identifies regions of the human genome that regulate gene expression may help scientists learn about and develop treatments for a number of human diseases, according to researchers at Duke's Institute for Genome Sciences & Policy (IGSP).
BioTek will present two opportunities for researchers to learn about new instruments and approaches to simplify their workflow at analytica 2016, the 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference.
› Verified 3 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
Sophiris Bio Inc. today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection.
Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.
A new resource that identifies regions of the human genome that regulate gene expression may help scientists learn about and develop treatments for a number of human diseases, according to researchers at Duke's Institute for Genome Sciences & Policy (IGSP).
BioTek will present two opportunities for researchers to learn about new instruments and approaches to simplify their workflow at analytica 2016, the 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference.
› Verified 3 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
Sophiris Bio Inc. today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection.
Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.
A new resource that identifies regions of the human genome that regulate gene expression may help scientists learn about and develop treatments for a number of human diseases, according to researchers at Duke's Institute for Genome Sciences & Policy (IGSP).
BioTek will present two opportunities for researchers to learn about new instruments and approaches to simplify their workflow at analytica 2016, the 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Chung, MD 330 Western Blvd Ste 102, Glastonbury, CT 06033-4383 Ph: (860) 547-0306 | Dr Stephanie Chung, MD 330 Western Blvd Ste 102, Glastonbury, CT 06033-4383 Ph: (860) 547-0306 |
News Archive
Sophiris Bio Inc. today announced data from its transrectal safety study, in which PRX302, the company's drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH or enlarged prostate), was well tolerated through three months following a transrectal injection.
Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.
A new resource that identifies regions of the human genome that regulate gene expression may help scientists learn about and develop treatments for a number of human diseases, according to researchers at Duke's Institute for Genome Sciences & Policy (IGSP).
BioTek will present two opportunities for researchers to learn about new instruments and approaches to simplify their workflow at analytica 2016, the 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference.
› Verified 3 days ago
Dr. Eugene Rozenshteyn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 305 Imperial Dr, Glastonbury, CT 06033 Phone: 201-835-5571 | |
Shannon Mckernan Sutherland, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 330 Western Blvd Ste 102, Glastonbury, CT 06033 Phone: 860-547-0306 Fax: 860-525-9782 |